Mainland China’s regulatory evolution brings greater access to novel drugs
Clarivate
MAY 11, 2023
Over the past five years, healthcare leaders in Mainland China have made significant strides in their efforts to reduce lag time in availability of novel drugs versus western markets. Despite the availability of multiple DMTs in the Western markets, there was a dearth of DMTs in Mainland China before 2018.
52 
Let's personalize your content